Clinical Topics & News

Are Periodic Endoscopies Useful for Patients Under 40?

Researchers determine whether a patient’s age affects the timing and outcome of gastric cancer screening.


 

Endoscopies do not necessarily help catch early gastric cancer in young people, say researchers from Severance Hospital, Seoul, and Hanyang University, Guri, both in Korea.

In countries such as Korea and Japan, where the researchers say Helicobacter pylori is endemic and gastric cancer is prevalent, screening for gastric cancer is recommended for people aged ≥ 40 years. In a previous study, they found that biennial endoscopies increased the diagnosis of gastric neoplasms, including gastric cancer and adenoma, at an early stage in people aged ≥ 40 years. Noting that disease-free status and overall survival of younger patients with gastric cancer are dependent on the cancer’s stage at diagnosis, as is the case with middle-aged patients, they wanted to find out whether earlier periodic endoscopies would be useful.

Related:Clarifying the Links Between Gallbladder Disease and Cancer

In their study, 101 patients underwent screening endoscopy within 24 months after receiving their gastric cancer diagnosis. Another 463 had not had an endoscopy within 2 years. Overall, 65% to 68% had early gastric cancer, but the researchers found no significant difference between the 2 groups. However, the proportion of lesions that were treated with endoscopic submucosal dissection (ESD) differed according to the interval: 9.8% for ≤ 24 and 4.5% for ≥ 24 months.

The only factor associated with early gastric cancer was gastrointestinal symptoms at the time of diagnosis.

Related: How Much Is Too Much Cancer Screening?

Performing an earlier endoscopy detected gastric cancer at a smaller size (23.8 mm in the ≤ 24-month group vs 30.5 mm in the ≥ 24-month group), which could facilitate treatment with ESD, the researchers say. They suggest that although not necessarily influencing early diagnosis, periodic endoscopies may help increase the proportion of lesions treated with ESD.

Source:
Park CH, Kim EH, Chung H, et al. PLoS One. 2016;11(7):e0159759.
doi: 10.1371/journal.pone.0159759.

Recommended Reading

Do Age and Gender Matter in Colorectal Cancer?
AVAHO
Managing Malignant Bowel Obstruction
AVAHO
What Patients Want to Know After Colorectal Surgery
AVAHO
Colorectal Carcinoma and Emerging Targeted Therapies
AVAHO
The Importance of Lymph Node Retrieval and Lymph Node Ratio in Male Patients With Colorectal Cancer: A 5-Year Retrospective Single Institution Study
AVAHO
Colorectal Cancer Statistics Among Patients Reported in the Veterans Affairs Central Cancer Registry
AVAHO
Utilization of Fusion PET/CT in Mapping Surgical/Medical Treatment Algorithms: Individualizing Patient Care for Suspicious Colorectal Masses
AVAHO
Patterns in the Use of Neoadjuvant and Adjuvant Therapy in Stage II/III Rectal Cancer and Associated Survival
AVAHO
Stage IV Rectal Cancer Trends by Year: A Review of the National Cancer Database, 1998 to 2009
AVAHO
Strollin’ the Colon: A Collaborated Effort to Provide Education and Screening Outreach for the Improvement of Awareness, Access, and Early Detection of Colorectal Cancer
AVAHO

Related Articles